How we do business

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

How we do business

Switching on to consumer choice: medicines for everyday health

How our consumer strategy is improving quality of life and access to established medicines

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

How we do business

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

How we do business

Biosecurity and pandemic preparedness

Our global commitment to helping ensure health for all is built on developing innovative medicines and vaccines and making sure they’re accessible to people around the globe.

How we do business

The hope for a cure for HIV/AIDS in our lifetime

In the past three decades, we’ve made advances in treatments for HIV/AIDS but a cure has remained elusive.

How we do business

Helping to Change the World

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

How we do business

Letting the sunshine in – transparency that’ll grow trust

Transparency for the sake of transparency seems a fruitless endeavor. Done right, however, it can be very powerful in strengthening relationships and forging new partnerships.

How we do business

How doctors and insurers get information about medicines

How do doctors and insurers in the US get the info they need to make decisions about medicines for patients?

How we do business

Buyer beware: importing drugs comes with big risks

At first blush, importing medicines sounds great – a patient without insurance or facing a high deductible or co-pay may find the prices quite attractive. But importation carries major risks.

How we do business

Changing the way we do business

When was the last time you upended your life – reevaluated the way you work, radically shifted how you measure success – and convinced 100,000 people to do it with you?

How we do business

Fast-tracking our response to pandemics

In the wake of global pandemics such as Ebola and Zika, there is consensus that the world needs to be better prepared.

How we do business

Putting it plainly

In our opinion, being transparent is not a path to failure — it is a source of strength.

How we do business

Hunting for energy savings

You never know what you might find when you hunt for waste.

How we do business

Creating bricks and benches out of medical waste

Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.

How we do business

Evolving our graduated approach to intellectual property

In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.

Our people

The gift of time: increased parental leave

We all want the time and energy to invest in the things that matter most. That is why GSK is expanding our paid parental leave benefit in 2017.

Back to top